Y-Trap Enters Collaboration With Merck Kgaa,To Develop Novel Antibody-Ligand Traps For Immuno-Oncology

Y-Trap, Inc. Has Signed A Collaboration And License Agreement With Merck Kgaa, Darmstadt, Germany, A Leading Science And Technology Company, For The Exclusive Development Of Multiple Specific Antibody-Ligand Traps For Cancer Immunotherapy.The Collaboration Leverages Y-Trap'S Proprietary Platform Of Multifunctional Antibody-Ligand Traps For Immuno-Oncology. The Y-Trap Platform Exploits Combinatorial Protein Engineering To Counteract Key Determinants Of Immune Dysfunction In The Tumor Microenvironment. Y-Trap And Merck Kgaa, Darmstadt, Germany, Will Collaborate To Explore The Pharmacology Of Y-Trap Multifunctional Proteins And Merck Kgaa, Darmstadt, Germany, Will Be Responsible For All Development, Manufacturing And Commercialization Activities.Under The Agreement, Merck Kgaa, Darmstadt, Germany, Will Provide Y-Trap With An Upfront Payment In Addition To Milestone Payments And Royalties Based On The Achievement Of Specific Pre-Clinical, Clinical Development, Regulatory, And Commercial Milestones."Cancers Evolve To Counteract And Defeat Immune Surveillance By Co-Opting And Amplifying Natural Mechanisms Of Immune Suppression," Said Atul Bedi, Md, Mba, Co-Founder And Chief Scientist Of Y-Trap, Inc. "Y-Trap'S Multifunctional Antibody-Ligand Traps Are Designed To Counteract Key Determinants Of Immune Tolerance To Entrain More Effective Antitumor Immunity. We Look Forward To Dovetailing The Respective Strengths Of Y-Trap And Merck Kgaa, Darmstadt, Germany, To Advance The Development Of Multiple Molecules From This Platform For Cancer Immunotherapy."

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!